258 related articles for article (PubMed ID: 11120281)
1. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
Transplant Proc; 2000 Nov; 32(7):2535. PubMed ID: 11120281
[No Abstract] [Full Text] [Related]
2. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk".
Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
Transplant Proc; 2000 Nov; 32(7):1688. PubMed ID: 11119893
[No Abstract] [Full Text] [Related]
3. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression.
Braun F; Canelo R; Lorf T; Schütz E; Grupp C; Müller GA; Ringe B
Transplant Proc; 2000 Feb; 32(1):115-6. PubMed ID: 10700989
[No Abstract] [Full Text] [Related]
4. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
[No Abstract] [Full Text] [Related]
5. Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
Braun F; Lorf T; Grupp C; Schütz E; Sattler B; Canelo R; Müller GA; Ringe B
Transplant Proc; 1998 Jun; 30(4):1221-3. PubMed ID: 9636496
[No Abstract] [Full Text] [Related]
6. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
7. Living unrelated kidney transplantation.
Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
[No Abstract] [Full Text] [Related]
8. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
[No Abstract] [Full Text] [Related]
9. Outcome of tacrolimus-treated renal transplantation from elderly donors.
Goto Y; Tanabe K; Tokumoto T; Kondo T; Ishikawa N; Toma H
Transplant Proc; 2000 Nov; 32(7):1723-5. PubMed ID: 11119908
[No Abstract] [Full Text] [Related]
10. Outcome of kidney transplantation from non-heart-beating donors followed by tacrolimus immunosuppression in japan.
Tanabe K; Takahashi K; Takahara S; Uchida K; Oshima S; Toma H; Sonoda T;
Transplant Proc; 2002 Aug; 34(5):1580-2. PubMed ID: 12176493
[No Abstract] [Full Text] [Related]
11. Tacrolimus-based immunosuppression in pediatric renal transplantation.
Jordan ML; Shapiro R; Scantlebury V; Vivas C; Ellis D; Lombardozzi-Lane S; Starzl TE
Transplant Proc; 1999 Nov; 31(7A):29S-30S. PubMed ID: 10576039
[No Abstract] [Full Text] [Related]
12. Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan.
Uchida K; Takahashi K; Takahara S; Oshima S; Toma H; Sonoda T;
Transplant Proc; 2002 Aug; 34(5):1606-7. PubMed ID: 12176503
[No Abstract] [Full Text] [Related]
13. Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up.
Lyne JC; Vivas CA; Shapiro R; Scantlebury VP; Hakala TR; Starzl TE; Jordan ML
Transplant Proc; 1997; 29(1-2):312. PubMed ID: 9123015
[No Abstract] [Full Text] [Related]
14. Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression.
Tanabe K; Ishida H; Tokumoto T; Shimmura H; Toda F; Omoto K; Makiyama K; Yagisawa T; Fuchinoue S; Teraoka S; Toma H
Transplant Proc; 2002 Aug; 34(5):1668-70. PubMed ID: 12176528
[No Abstract] [Full Text] [Related]
15. Excellent results following 3 years of tacrolimus immunosuppression in kidney transplantation recipients in Japan: overall analysis of more than 1000 patients.
Takahara S; Takahashi K; Uchida K; Oshima S; Toma H; Sonoda T;
Transplant Proc; 2002 Aug; 34(5):1597-9. PubMed ID: 12176500
[No Abstract] [Full Text] [Related]
16. Long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart-beating donors.
Fukuhara N; Ono Y; Kinukawa T; Hattori R; Nishiyama N; Yamada S; Kamihira O; Ohshima S
Transplant Proc; 2002 Aug; 34(5):1577-9. PubMed ID: 12176492
[No Abstract] [Full Text] [Related]
17. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
[No Abstract] [Full Text] [Related]
19. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
[No Abstract] [Full Text] [Related]
20. FK 506 in cadaveric kidney transplantation from non-heart-beating donors.
Hattori R; Ohshima S; Ono Y; Fujita T; Kinukawa T; Matsuura O
Transplant Proc; 1998 Nov; 30(7):3801-3. PubMed ID: 9838666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
